The mutations described in the following sub-sections commonly co-exist with JAK2, MPL, and CALR mutations in patients with myelofibrosis and, while they fall within broad categories (such as proteins affecting splicing and epigenetic regulation), each has its own unique mechanism. This evidence concerns the gene MPL and myelofibrosis.